GT201300067A - Nuevos derivados dihidrobenzoxatiazepinas. su procedimiento de preparacion y las composiciones farmaceuticas que los - Google Patents

Nuevos derivados dihidrobenzoxatiazepinas. su procedimiento de preparacion y las composiciones farmaceuticas que los

Info

Publication number
GT201300067A
GT201300067A GT201300067A GT201300067A GT201300067A GT 201300067 A GT201300067 A GT 201300067A GT 201300067 A GT201300067 A GT 201300067A GT 201300067 A GT201300067 A GT 201300067A GT 201300067 A GT201300067 A GT 201300067A
Authority
GT
Guatemala
Prior art keywords
new
dihydrobenzoxatiazepinas
derivatives
pharmaceutical compositions
preparation procedure
Prior art date
Application number
GT201300067A
Other languages
English (en)
Inventor
Cordi Alexis
Desos Patrice
Lestage Pierre
Danober Laurence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43067253&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201300067(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT201300067A publication Critical patent/GT201300067A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A LA FORMULA 1, FENOXI-3 ,4-DIHIDRO-2H-BENZO [B] [1,4,5] COMPUESTOS OXATHIAZEPINE-DIÓXIDO DE (I) Y SUS ENANTIÓMEROS Y DIASTEREOISÓMEROS, ASÍ COMO SALES DE ADICIÓN CON UN ÁCIDO O UNA BASE, SON NUEVOS. QUE SIRVAN COMO MEDICAMENTOSTRANQUILIZANTES, ANTIDEPRESIVOS, NEUROPROTECTORES, ANTIPARKINSONIANOS, ANTICONVULSIVOS ETC.
GT201300067A 2010-09-16 2013-03-14 Nuevos derivados dihidrobenzoxatiazepinas. su procedimiento de preparacion y las composiciones farmaceuticas que los GT201300067A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1003683A FR2964969B1 (fr) 2010-09-16 2010-09-16 Nouveaux derives dihydrobenzoxathiazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
GT201300067A true GT201300067A (es) 2014-07-08

Family

ID=43067253

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201300067A GT201300067A (es) 2010-09-16 2013-03-14 Nuevos derivados dihidrobenzoxatiazepinas. su procedimiento de preparacion y las composiciones farmaceuticas que los

Country Status (40)

Country Link
US (1) US8569285B2 (es)
EP (1) EP2431360B1 (es)
JP (1) JP2013537216A (es)
KR (1) KR20130054438A (es)
CN (1) CN103153973A (es)
AP (1) AP2013006793A0 (es)
AR (1) AR082973A1 (es)
AU (1) AU2011213898A1 (es)
BR (1) BR112013005967A2 (es)
CA (1) CA2752131C (es)
CL (1) CL2013000655A1 (es)
CO (1) CO6680709A2 (es)
CR (1) CR20130105A (es)
CU (1) CU20130037A7 (es)
CY (1) CY1114110T1 (es)
DK (1) DK2431360T3 (es)
EA (1) EA201300340A1 (es)
EC (1) ECSP13012489A (es)
ES (1) ES2421504T3 (es)
FR (1) FR2964969B1 (es)
GE (1) GEP20156247B (es)
GT (1) GT201300067A (es)
HR (1) HRP20130505T1 (es)
IL (1) IL225209A0 (es)
MA (1) MA34529B1 (es)
ME (1) ME01524B (es)
MX (1) MX2013002892A (es)
NI (1) NI201300028A (es)
PE (1) PE20131342A1 (es)
PL (1) PL2431360T3 (es)
PT (1) PT2431360E (es)
RS (1) RS52835B (es)
SA (1) SA111320755B1 (es)
SG (1) SG188380A1 (es)
SI (1) SI2431360T1 (es)
TW (1) TWI421080B (es)
UA (1) UA105320C2 (es)
UY (1) UY33574A (es)
WO (1) WO2012035216A1 (es)
ZA (1) ZA201106353B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111518058B (zh) * 2020-05-29 2021-03-09 四川大学华西医院 一种噁噻嗪类化合物及其用途
CN111559990B (zh) * 2020-05-29 2021-03-09 四川大学华西医院 一种小分子噁噻嗪类衍生物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA991301B (en) * 1998-02-18 1999-09-13 Neurosearch As Glutamate receptor modulators.
TWI232863B (en) * 2001-06-11 2005-05-21 Akzo Nobel Nv Benzoxazepine derivatives
SK287583B6 (sk) * 2001-06-14 2011-03-04 N.V. Organon (Pyrido/tieno)-[f]-oxazepin-5-ónové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
FR2856064B1 (fr) * 2003-06-13 2005-08-19 Servier Lab Nouveaux derives de benzothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
TW200714597A (en) * 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
CL2013000655A1 (es) 2013-08-09
HRP20130505T1 (hr) 2013-07-31
ME01524B (me) 2014-04-20
CR20130105A (es) 2013-05-16
SG188380A1 (en) 2013-04-30
SA111320755B1 (ar) 2013-11-10
UY33574A (es) 2012-03-30
UA105320C2 (ru) 2014-04-25
FR2964969B1 (fr) 2012-08-24
US8569285B2 (en) 2013-10-29
NI201300028A (es) 2014-01-07
RS52835B (en) 2013-10-31
MA34529B1 (fr) 2013-09-02
SI2431360T1 (sl) 2013-07-31
DK2431360T3 (da) 2013-07-22
CO6680709A2 (es) 2013-05-31
BR112013005967A2 (pt) 2016-05-03
ES2421504T3 (es) 2013-09-03
MX2013002892A (es) 2013-04-10
EP2431360A1 (fr) 2012-03-21
ZA201106353B (en) 2012-05-30
WO2012035216A1 (fr) 2012-03-22
CU20130037A7 (es) 2013-05-31
PL2431360T3 (pl) 2013-08-30
AR082973A1 (es) 2013-01-23
TW201212921A (en) 2012-04-01
IL225209A0 (en) 2013-06-27
FR2964969A1 (fr) 2012-03-23
AU2011213898A1 (en) 2012-04-05
AP2013006793A0 (en) 2013-04-30
EA201300340A1 (ru) 2013-08-30
EP2431360B1 (fr) 2013-04-17
PE20131342A1 (es) 2013-11-28
CA2752131C (fr) 2014-04-22
ECSP13012489A (es) 2013-04-30
JP2013537216A (ja) 2013-09-30
CN103153973A (zh) 2013-06-12
US20120071462A1 (en) 2012-03-22
PT2431360E (pt) 2013-05-14
KR20130054438A (ko) 2013-05-24
CA2752131A1 (fr) 2012-03-16
TWI421080B (zh) 2014-01-01
GEP20156247B (en) 2015-02-10
CY1114110T1 (el) 2016-07-27

Similar Documents

Publication Publication Date Title
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
CU20130082A7 (es) 1,2 oxazol-8-azabiciclo[3,2,1]octano 8 il como moduladores de fxr
DOP2013000142A (es) Derivados de biciclo[3,2,1]octilamida y sus usos.
UY31481A1 (es) Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones
CR10148A (es) Derivados de las benzamidas y heteroarenos
UY31189A1 (es) Compuestos heterocíclicos
UY31260A1 (es) Compuestos de pirazol, composiciones conteniendolos y aplicaciones.
UY32611A (es) Compuestos de 1-cianoetilheterociclilcarboxamida sustituidos 750
DOP2009000227A (es) Derivados de aril isoxazolina insecticidas
UY30859A1 (es) Nuevos derivados de 2-anilino-4-heteroarilpirimidinas , su preparacion, como medicamentos, composiciones farmacéuticas y especialmente como inhibidores de ikk
GT201400144A (es) Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
UY33201A (es) Compuestos de pirazol como antagonistas de crth2.
UY30856A1 (es) Nuevos derivados de 2,4 dianilinopirimidinas, su preparacion, como medicamentos, composiciones farmacéuticas y principalmente como inhibidores de ikk
CU20140095A7 (es) Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
ECSP14013215A (es) Compuestos novedosos
CO6741154A2 (es) Compuestos de triazolopiridina
CR20110269A (es) Lactamas como inhibidores de beta secretasa
CR20110680A (es) Sulfonamidas heterociclicas, usos y composiciones farmacéuticas de las mismas
UY31905A (es) Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones.
GT200900309A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
ECSP13012838A (es) Nuevos compuestos de benzodioxol-piperazina
UY30933A1 (es) Derivados de pentafluorotiobenzamidoacetonitrilo, composiciones farmacéuticas que contienen tales compuestos y aplicaciones.
GT201300067A (es) Nuevos derivados dihidrobenzoxatiazepinas. su procedimiento de preparacion y las composiciones farmaceuticas que los
UY32333A (es) Derivados cuaternarios de piridina y utilización de los mismos